.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

COVID-19
Sickle Cell Disease
Strains of C. Difficile

ClinicalSee All >

ADHD
Allergy
Arterial Disease
Cardiology
Dermatology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Inflammation
Neurology
Psychiatry
Pulmonology
Rheumatology

Video Series

Insights
News Network
Peers & Perspectives
Post Conference Perspectives

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

Biologic Treatment Considerations for Asthma During the COVID-19 Pandemic and the Upcoming Flu Season

EP. 1: Overview of Uncontrolled Asthmatic Episode

November 18th 2020

EP. 2: Quality of Life and Increased Risk of Asthma Exacerbations

November 18th 2020

EP. 3: Over and Under Diagnosis of Asthma

November 18th 2020

EP. 4: Targeted Pathology for the Treatment of Asthma

November 18th 2020

EP. 5: Common Biomarkers of Asthma to Determine Treatment Efficacy

November 18th 2020

EP. 6: Raising Awareness Among Physicians Regarding Biologics

November 18th 2020

EP. 7: FDA Approved Agent Omalizumab for Asthma

November 18th 2020

EP. 8: Patient Factors That Determine the Use of Omalizumab in Asthma

November 18th 2020

EP. 9: IL-5 Inhibitors for Treatment of Asthma

November 18th 2020

EP. 10: Dupilumab for Moderate to Severe Asthma

November 18th 2020